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Abstract: We describe an innovative strategy to generate catalytic compartments with 
triggered functionality at the nanoscale level by combining pH-reversible bio-valves and 
enzyme-loaded synthetic compartments. The bio-valve has been engineered by attachment of 
stimuli-responsive peptides to a genetically modified channel porin, enabling a reversible 
change of the molecular flow through the pores of the porin in response to a pH change in the 
local environment. The bio-valve functionality triggers the reaction inside the cavity of the 
enzyme-loaded compartments by switching the in situ activity of the enzymes on/off based on 
a reversible change of the permeability of the membrane, which blocks or allows the passage 
of substrates and products. The complex functionality of our catalytic compartments is based 
on preservation of the integrity of the compartments to protect encapsulated enzymes. An 
increase of the in situ activity compared to that of the free enzyme, and a reversible on/off 
switch of the activity upon the presence of a specific stimulus is achieved. This strategy 
provides straightforward solutions for development of catalytic nanocompartments efficiently 
producing desired molecules in a controlled, stimuli-responsive manner with high potential in 
areas, such as medicine, analytical chemistry, and catalysis.  
 
Keywords: stimuli-responsiveness; catalytic nanocompartment; membrane-protein; triggered 
bio-activity; reversible permeability 
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In nature, controlled transport of molecules between cellular and subcellular compartments is 
vital for functional cellular metabolism and is achieved via delicate molecular mechanisms 
involving membrane proteins (MPs). A plethora of MPs located in cellular phospholipid 
bilayers allow active or passive transport of molecules through the compartment membrane. 
Such molecular transport is frequently triggered by stimuli such as pH or temperature change, 
transmembrane potential, light, or the presence of specific molecules.1-3 A bioinspired 
strategy on focus today for development of new materials is based on interfacing 
biomolecules such as MPs, enzymes, and proteins with synthetic membranes (planar 
membranes and compartments).4, 5 Such bio-nanoassemblies combine the activity of 
biomolecules with the architecture of a synthetic assembly, generating new materials with 
emergent properties and functionality that have high potential in various domains of 
technology, medicine and environmental sciences.5-7 Bio-nanoassemblies have been designed 
as models in order to understand the activity of biomolecules in synthetic matrixes proposed 
as artificial organelles,8, 9 molecular motors,10 and simple models of artificial cells.11 In 
addition, bio-nanoassemblies have been developed for applications, such as local synthesis of 
polymers,12 active surfaces serving for production of antibiotics13 or sensitive biosensing,14 
and membranes for water purification.15  
Particularly interesting are catalytic compartments named nanoreactors which are based on 
encapsulation of active compounds (proteins, enzymes, mimics) in the cavity of 
compartments where they are able to fulfil their function of protected reactions at the 
nanoscale.5, 16 These catalytic compartments can be used to study enzymatic reactions in 
confined spaces, or for specific applications such as detoxification of reactive oxygen species 
and storage of oxygen,17 enzyme-mediated biotransformation,18 synthesis of polymers,12 or 
even as simple mimics of cell organelles.19-21 Polymer vesicles are particularly appealing 
compartments, with sizes ranging from nanometers (polymersomes) up to micrometers 
(synthetic giant unilamellar vesicles, synthetic GUVs). In comparison to liposomes (lipid 
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based compartments closely related to cell membranes), polymer compartments have specific 
advantages arising from the intrinsic chemical nature of the polymers: i) greater mechanical 
stability, ii) tunable membrane properties (thickness, flexibility, composition), and iii) ability 
to be functionalized with different molecular groups.22-24 Appropriately selected amphiphilic 
copolymers that self-assemble into polymersomes or GUVs can be both nontoxic and 
responsive, changing their architecture in the presence of a specific stimulus, properties 
largely exploited for development of drug delivery systems.25 However in the case of the 
catalytic compartments, it is not possible to use stimuli-responsive polymers that change their 
architecture, because their irreversible disassembly would lead to the release of the active 
compounds.26, 27 
Membrane permeability is an essential property for in situ reactions inside catalytic 
compartments, to allow the reaction substrates to pass inside and products to be released. 
Polymer membranes have been rendered permeable by various approaches: i) using 
copolymers which generate porous membranes,28-30 ii) inducing pores by chemical 
treatment,12, 18, 31 or iii) mimicking cell membranes by insertion of biopores and MPs.6 Once 
reconstituted in polymersome membranes, MPs such as AqpZ, LamB, OmpF, Tsx and FhuA6, 
32, 33 and membrane penetrating peptides such as gramicidin34, 35 allow diffusion of ions and 
small molecular weight molecules with a selectivity based on their intrinsic properties. In 
order to develop stimuli-responsive compartments that preserve their architecture as well as 
support in situ reactions, a biomimetic approach is to use appropriate MPs to induce 
responsiveness. To date only a few liposome and polymersome membranes have been 
permeabilized by insertion of modified channel proteins that possess stimuli-
responsiveness.36, 37 The membrane proteins have been modified to equip them with a 
cleavable responsive molecular cap, which is cleaved in the presence of a specific stimulus, 
and the molecular flow through the pore is restored. Stimuli responsive protein pores were 
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designed to react to external changes in pH (OmpF,36, 38 MS-CL39) or reduction potential 
(FhuA40, 41). Another approach to obtain stimuli responsive MPs is based on using amino acid 
mutations, to create charge repulsion in the channel interior (OmpF),38 or introduce an elastin-
like polypeptide loop with temperature triggered solubility.42 A more appealing approach for 
practical applications, which involves a permanent attachment of a stimuli responsive 
molecular group, has been applied only to ion channels.43, 44 Unfortunately, such engineered 
ion channels cannot be used as “gates” for catalytic compartments, because they do not allow 
the diffusion of small molecular weight enzymatic substrates. 
We introduce here a biomimetic strategy to develop catalytic compartments with controlled 
functionality triggered in a stimuli-responsive manner by changes in the compartments 
environment. The catalytic compartments with reversibly triggered activity are obtained by 
introducing into the synthetic membrane of enzyme-loaded polymersomes bio-valves based 
on modified membrane proteins. Bio-valves were engineered by attaching molecules able to 
change the conformation and properties of channel porins in specific conditions. These 
attached molecules enable reversible opening and closing of the porin pores, depending on 
environmental conditions. Such bio-valves can efficiently switch on/off in situ activity when 
inserted in the membrane of the compartments (Figure 1). We selected OmpF as a model 
channel porin, because of its well characterised crystal structure, remarkable stability 
(temperature, solvents, detergents and pH),38, 45, 46 and moderate pore size, allowing molecules 
of up to 600 Da to pass through.38, 46 In order to favour the attachment of a molecular cap, we 
genetically engineered OmpF through point mutation to feature two cysteine residues in 
specific positions on the channel interior (OmpF-M), and then attached a peptide to those 
cysteines. Changes in pH induce this peptide to make reversible conformational changes and 
thus block (closed state) or unblock (open state) the pore of the peptide-OmpF-M conjugate 
(OmpF-C). OmpF-C was inserted into the membrane of polymersomes based on poly(2-
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methyl-2-oxazoline)-block- poly(dimethylsiloxane)-block poly(2-methyl-2-oxazoline) 
(PMOXA-b-PDMS-b-PMOXA) loaded with Horseradish Peroxidase (HRP). We selected 
PMOXA- b-PDMS- b-PMOXA amphiphilic triblock copolymers for self-assembly into 
polymersomes because of their flexible membranes and previously reported ability to 
successfully incorporate MPs.47 In situ activity of HRP was followed during reversible 
changes in pH to evaluate the open/close functionality of OmpF-C.  
Our approach is a resourceful strategy to design a reversible gating system that it is not 
restricted to a single “activation” of the catalytic compartment by opening the pores but can 
be switched on and off over several cycles, potentially maintaining stimuli-responsiveness for 
long-term utilization. Both, a reversible and precise response in time and space upon an 
external stimulus and the large variety of possible applications by encapsulation of 
appropriate active compounds (enzyme, proteins, mimics) highlight the potential of our 
system in areas such as medicine, catalysis, and technology, where such materials will 
provide desired processes/compounds “on demand”.  
To induce stimuli responsiveness of the OmpF porin, we attached a pH-responsive peptide 
capable of significant changes in charge and conformation upon changes of pH from 7.4 to 
6.0. Each of the pH-responsive amino acid groups must be accompanied by hydrophobic 
amino acids, in order to create a more pronounced change in solubility between different 
protonation states, and to be obtained by a straightforward synthesis and purification 
procedure. An example of a peptide sequence that meets these requirements is GALA 
(WEAALAEALAEALAEHLAEALAEALEALAA), previously reported to change its 
polarity and conformation producing two distinct states pH 5.5 and 7.5.48 In addition, the 
peptide sequence has to be adapted to the geometric constrains of the elliptical OmpF pore 
with an inner diameter of 7-11 Å.46 
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Figure 1. Schematic representation of a bio-valve functioning by reversible pore opening and 
closing inside the membrane of nanocompartments to trigger an in situ reaction (left: closed 
state; right open state). Modified OmpF pore (purple; stimuli responsive group green) is 
inserted in the polymersome membrane that separates the encapsulated enzyme (HRP) from 
the environment. The in situ reaction is triggered by the bio-valve functionality, which allows 
the diffusion through the OmpF pores of the substrate Amplex UltraRed® (magenta spheres) 
and the subsequent release of the fluorescent products (yellow stars). 
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Only peptides with a total length of 20-50 Å are suitable to block the pore, considering that 
both random coil and α-helix structures are significantly shorter than the corresponding 
stretched peptide (Figure 2). In this respect, a GALA sequence shortened to 
LAEALAEALAEA (Gala3) is an optimum peptide sequence matching the requirement of 
closing the OmpF pore, and thus we selected it for this purpose. In order to allow a significant 
change in protonation, at least three carboxylic acids were incorporated in the peptide 
structure. Considering the neighbouring hydrophobic amino acids, the minimal length 
requirement for the peptide sequence is indeed obtained with Gala3. 
In order to attach the responsive peptide to the channel protein, first OmpF was genetically 
modified to introducing cysteine residues at key locations in the OmpF amino acid sequence. 
The mutation sites K89C (lysine) and R270C (arginine) located inside the pore in the eyelet-
region were replaced by cysteines (Figure 2) as anchoring points for the attachment of 
molecular groups that can block the molecular flow at the beginning of the pore or point 
outwards without obstructing the pore, in different conditions. (Figure 2B) 3D representations 
of OmpF-C (Figure 2C) were obtained using Pymol and the crystal structure of OmpF wild 
type from the RSCB Protein database with the cysteines residues attached. We used two 
mutations in order to increase the labelling efficiency of the porin, and to offer better 
conditions to block the OmpF pore because two peptides will occupy more space inside the 
pore. 
The mutation was performed via polymerase chain reaction (PCR) of the entire plasmid. The 
K89C-mutation was introduced first, and then the R270C-mutation was introduced by the 
same procedure. The plasmid was shifted to higher masses than the template (unmodified 
plasmid), which remained supercoiled (Figure S1). After purification via gel-electrophoresis, 
the PCR product was isolated and sequenced, confirming the mutation (Table S2, Supporting 
Information). The double mutant of the porin, K89C-R270C-OmpF (OmpF-M) was then 
overexpressed in Omp8 E.coli. Its excess over naturally occurring OmpF-WT made further 
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separation unnecessary. OmpF-M could not be distinguished on gel from OmpF-WT or single 
mutants K89C-OmpF and R270C-OmpF, indicating a successful expression and good purity, 
because of the lack of additional bands in the Coomassie stained gel (Figure S2, S3, 
Supporting Information). The occasionally observed splitting of the OmpF band (Figure S2) is 
attributed to the presence of residual signalling peptide (2000 Da).49 An OmpF-M 
concentration of 0.75±0.25mg/mL (extract without further concentration steps) was 
determined by BCA total protein assay®. The presence of thiol groups and their accessibility 
was evaluated by binding them with the thiol-reactive fluorophore acrylodane. As expected, 
OmpF-WT did not reveal any fluorescence intensity upon addition of acrylodane, indicating 
the lack of nonspecific binding of the fluorophore to the porin. On the contrary, the 
fluorescence intensity of acrylodane when added to the thiol-bearing mutants (K89C-OmpF, 
R270C-OmpF and OmpF-M), clearly indicates successful thio-functionalization of the porin. 
Moreover, the fluorescence intensity of acrylodane when bound to the double mutant OmpF-
M was similar to that resulting from a double concentration of R270C-OmpF bound to 
acrylodane (Figure S5, Supporting Information), indicating that both thiol groups are 
accessible, and can bind to small molecular weight molecules. To attach Gala3 to the thiols of 
the cysteine residues in the OmpF-M, Michael addition was chosen due to its straightforward 
approach, fewer side-reactions compared to disulphide bonds formation with the cysteine 
residues, or to direct alkylation of the cysteine residues with halogenoalkanes.50, 51 In addition, 
the chosen glycine maleic imide linker between OmpF-M and Gala3 is a small molecule (97 
Da) and expected to have no impact on substrate translocation through the pore due to its 
small size. 
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Figure 2. A. Michael addition of the Gala3 peptide to the cysteine side chains of the OmpF-
M; B. Location of the mutation sites K89 and R270 (highlighted only in one of the three 
channels of the OmpF trimer) and a schematic representation of the cross-section of the pore 
in “closed state”, with Gala3 blocking the entrance of the pore (above) and in “open state”, 
with the attached Gala3 freely moving in its random-coil state (below). C. Three-dimensional 
representation of OmpF-C after binding of the pH responsive peptide Gala3 (green) attached 
in helical structure (compact state) to cysteine residues (blue) of OmpF-M showing closing of 
the pore: view from the side (I), and from the top (II).  
 
The degree of labelling (DOL) of the double mutant OmpF-M with Gala3 (OmpF-C) was 
determined using a combination of mass spectrometry (MS), and the acrylodane assay. For 
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the prior, OmpF-C and OmpF-M were purified via SDS-gel electrophoresis and digested 
within the gel, resulting in various peptides. Mass spectroscopy is a direct and absolute 
method for quantification, however, long hydrophobic peptides are particularly difficult to 
ionize and transfer into the gas phase. Such peptide sequences are typical for membrane 
proteins such as OmpF.52 Thus it was necessary to perform an indirect measurement by 
comparing the ratio between the intensities of the mass peaks of the cysteine-bearing OmpF 
fragment without Gala3 with another peptide without cysteine, and calibrating it with OmpF-
M. (Equation 2; Supporting Information) This eliminated the dependency on the protein 
concentration, as the other peptide served as an internal standard. The measurements indicate 
that 94% ± 5% of the thiol groups within the double mutant OmpF-M bound Gala 3 (92% ± 
5% of K89C- and 96% ± 5% of R270C anchor points had the Gala3 peptide attached) (Table 
S3). We used as a complementary qualitative assay, the acrylodane assay, which is based on 
binding of acrylodane to the accessible thiol groups that remain unbound after the attachment 
of Gala3. A DOL value of 68% ± 9% was obtained, indicating a successful binding of Gala3 
to the modified OmpF (Figure S4, Supporting Information, Table S4). DOL value determined 
with the acrylodane assay was lower than determined by mass spectroscopy due to 
fluorophore interactions with aromatic amino acid residues.53, 54 However, both MS and the 
acrylodane assay indicate successful thio-functionalization of the OmpF-M, as an essential 
step for the attachment of Gala3. 
A second step in obtaining reversible pH-responsive catalytic compartments was to insert 
OmpF-C into polymersome membranes together with simultaneous encapsulation of an 
enzyme inside the cavity, and then to test the overall functionality. We used the rehydration 
method to generate catalytic compartments,55 NR, by self-assembly of PMOXA6-b-PDMS44-
b-PMOXA6 amphiphilic block copolymers in the presence of: HRP (NR-), HRP and OmpF-C 
(NRC), and HRP OmpF-M (NR+). OmpF-C/-M were directly added to an ethanolic 
copolymer solution before drying until a thin polymer film was formed. Slow hydration with 
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biomolecule solutions in PBS induced the self-assembly process and formation of 
polymersomes containing the biomolecules in specific locations depending of their intrinsic 
character: OmpF-C/-M in the membrane, with HRP inside the cavity. In general, the 
efficiency and homogeneity of polymersome formation, and OmpF insertion depend on 
numerous factors, as for example the presence of surfactants, such as octylglucopyranoside 
(OG), used in the membrane protein extraction and stabilisation.56 (Figure S9, Supporting 
Information). Since OG was only required for the initial steps of OmpF extraction and the 
stabilisation in solution, its concentration was reduced to the minimal possible concentration 
for storage (0.5 w/w %), and was further removed prior to mixing it with the copolymer 
solution. Before dialysis, polymersome size was controlled by extrusion through 0.2 µm 
polycarbonate filters. Polymersome solutions were diluted to the same concentration 
(determined by their respective ability to scatter light). The final polymersome concentration 
was considered as the lowest concentration determined for NR-, NRC and NR+. The 
homogeneity of the polymersomes size was confirmed by dynamic light scattering as with a 
PDI < 0.2.  
The size and the architecture of the polymer assemblies resulting from the self-assembly of 
the copolymers without and with the biomolecules were determined by static and dynamic 
light scattering, SLS and DLS (Table 1; Figure S6-S8, Supporting Information).  
Table 1: Light scattering parameters of: HRP loaded polymersomes (NR-), HRP loaded 
polymersomes with inserted OmpF-C (NRC), and HRP loaded polymersomes with inserted 
OmpF-M (NR+). 
 
 
pH 7.4 
  
pH 6.0 
 
 
NR- NRC NR+ 
 
NR- NRC NR+ 
Rg [nm] 
 
61±8 58±4 61±3 
 
61±1 62±2 63±2 
Rh [nm] 
 
64±8 61±4 64±3 
 
66±2 65±2 67±2 
ρ [] 
 
0.96 0.94 0.95 
 
0.93 0.95 0.93 
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The ratio (ρ) between the hydrodynamic radius (Rh) and radius of gyration (Rg) was close to 1 
indicating that the polymer assemblies have hollow sphere architecture.57  
TEM micrographs indicate that there were no significant differences in size and architecture 
between polymersomes loaded with HRP without OmpF (NR-) and those containing HRP 
with different OmpF mutants inserted (NR+ and NRC) (Figure S10-S12, Supporting 
Information). The diameter of the polymersomes obtained by TEM is between 50-120 nm, in 
agreement with the light scattering results (Table 2). In addition, polymersome NRs (without 
and with inserted OmpF-M/C) were stable at room temperature at both pH 7.4 and 6.0 for 
several days. Cryo-TEM micrographs clearly indicate that the membrane integrity is 
preserved upon insertion of OmpF-C, and confirm the size obtained by TEM analysis (Figure 
3). Unlike the other methods, cryo-TEM revealed a minor population of worms, but which is 
not interfering with the bio-valve insertion and functionality.  
  
Figure 3: Cryo-TEM micrograph of A) HRP loaded PMOXA6- b-PDMS44- b-PMOXA6 
polymersomes equipped with OmpF-C, NRC, and B) HRP loaded PMOXA6- b-PDMS44- b-
PMOXA6 polymersomes without OmpF, NR-. Scale bar 100nm. 
 
A B
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Before analysing the influence of the pH change on the activity of the catalytic compartments, 
the behaviour of free HRP was investigated, since enzymes have an optimal pH and a window 
of operation and stability. HRP presented a pH dependent activity, with an activity 
significantly higher at pH 6.0 than at pH 7.4 (Figure 4A), but becoming irreversibly 
deactivated below pH 5.0.58, 59 Cycling pH changes between 7.4 and 6.0 revealed that the free 
enzyme lost its activity very fast. Already after the first full cycle of pH change, a drop in 
activity of the free HRP up to 12.5% of its initial value was observed, and it further decreased 
after the second complete pH change cycle. The decrease in enzymatic activity of the free 
HRP was mainly due to the adjustment of pH with small amount of concentrated HCl in order 
to avoid dilution. A temporary, local pH decrease below the final pH probably deactivated the 
enzyme58, 59 (Figure 4C and S13 Supporting Information). There are other factors resulting in 
a drop of the perceived activity as well, as for example the accumulation of salt and 
fluorophores after each cycle that contributed to the reduction of the detected fluorescence 
intensity. 
The low activity of the free HRP after the second pH change cycle remained higher at pH 6.0 
than at pH 7.4, but the enzyme did not recover (Figure 4B). This significant decrease in free 
HRP activity indicates the possible effect of harmful conditions in biosystems in the case of 
the free enzyme, as for example local changes in pH or a proteolytic attack. Therefore it 
induces the necessity to protect the enzyme when desired applications are planned, and 
supports our approach of development of catalytic nanocompartments. Catalytic 
nanocompartments play in biologic conditions a dual role: they shield the enzymes from local 
harmful conditions and proteolytic attack, whilst allowing them to perform their activity in 
situ.  
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Figure 4. A) Activity of HRP based on the increase in fluorescence intensity of HRP product, 
measured at pH 7.4 and pH 6: free HRP (black), NR- (blue), NRC (green), and NR+ (red). 
The stars indicate the statistical significance (P value; Table S6 Supporting Information). B) 
Free HRP activity after changing the pH from 7.4 to 6.0, and adding Amplex UltraRed® and 
H2O2 in each cycle. Green: pH 7.4 and red: pH 6.0. C) Bio-valve functionality of OmpF-C 
when inserted into the membrane of HRP loaded polymersomes (NRC) after changing the pH 
from 7.4 to 6.0, and adding Amplex UltraRed® and H2O2 in each cycle. Green: pH 7.4 and 
red: pH 6.0. The activities were corrected by taking the volume increase into account.  
 
Stimuli responsiveness of the OmpF-C equipped membranes was evaluated by the in situ 
activity of encapsulated HRP at pH 6.0 and 7.4 both after the first pH cycle (Figure 4A), and 
after several cycles (Figure 4C). The increase of fluorescence intensity associated with the 
formation of resorufin-derivative inside the cavity of polymersome NRs represents a direct 
measure for the transmembrane diffusion of the HRP substrate. Polymersomes loaded with 
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HRP, but without inserted OmpF, (NR-) had a very low residual activity after dialysis, size 
exclusion chromatography and treatment with proteinase K (Supporting Information 
polymersome preparation). In order to understand the cause of this residual HRP activity in 
NR-, interactions of residual HRP traces with the membrane during the polymersomes 
formation have been evaluated by addition of HRP in the environment of the polymersomes, 
and subsequent dialysis. Only HRP activity at the detection limit has been observed, which 
indicates no HRP bound on the external side of the membrane (Figure S14). Therefore, the 
residual activity of NR- is probably due to the partition of Amplex UltraRed between the 
aqueous phase and the hydrophobic membrane, resulting in a very small fraction of auto-
oxidised Amplex UltraRed in the presence of H2O2. 
The initial HRP activities of the NRs (NRC, NR-, NR+) were normalised for a simpler 
comparison, such that the highest activity of NR+ was set to 100%. (Figure 4, Figure S175-
18, Table S5, Supporting Information). HRP activity values represent the mean value of three 
independent measurements. A remarkable stimuli-response of the catalytic compartment 
containing HRP was observed for a pH change of only 1.4 units: in situ HRP activity inside 
NRC decreased up to 20% of the activity at pH 7.4 upon the decrease of pH at 6.0, thereby 
changing from an activity close to NR+ to an activity close to the low residual activity of NR- 
(Figure 4A), completely overriding the pH-dependency of free HRP. This indicates, within 
the error limits, a change of the OmpF-C pore from an “open state” (pH 7.4) to a “closed 
state” (pH 6.0) due to a conformational change of Gala3 inside OmpF-C. The pH-responsive 
change in the accessibility of OmpF-C for molecular diffusion triggered in situ HRP activity, 
and induced a functionality change from an “active” catalytic compartment to a “non-active” 
one. This pH-dependent behaviour allows the catalytic nanocompartments to start their 
activity “on demand” by a simple pH change. At pH 6.0, where OmpF-C is in “closed” state, 
the catalytic compartment has low functionality, even if inside the cavity HRP is active, and 
expected to have a higher activity compared to that at pH 7.4 (Figure 4A, free HRP and 
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NRC). On the contrary, when OmpF-C is in an “open” state, substrates pass through the 
membrane and the functionality of the catalytic compartment is fully restored due to the 
intrinsic activity of HRP. Interestingly, both the enzyme activity of NRC and that of the 
catalytic nanocompartment with OmpF-M, NR+, is significantly higher at pH 7.4 than that of 
the free HRP at this pH, matching the activity value of the free HRP at pH 6.0 (Figure 4A). 
Note that the increase of the enzyme activity inside the confined space of the polymersome 
cavity compared with bulk assays was observed in similar conditions (amount of enzyme, 
ratio of substrates). The increase in activity upon encapsulation of enzymes inside nano-
compartments is due to the effect of the confined nano-space, which enhances the interaction 
of the enzymes with the substrates.60 Inside the cavity of polymersomes there is an increase in 
the probability of interaction between the enzyme molecules and their substrates due to an 
increase of the duration the substrates are remaining in proximity of the enzymes. In addition, 
the impermeable synthetic membrane allows molecular transport through and thus in situ 
enzymatic reaction when the pores of OmpF-C are open, and serve for a rapid diffusion of 
substrates/products. We estimated that for a 125nm diameter polymersome the mean number 
of porin molecules per vesicle is around 11 OmpF molecules/vesicle have been inserted in the 
conditions we used for OmpF insertion (Supporting Information). 
 The stimuli response behaviour of OmpF-C inserted in polymersome membranes was 
reproducible (raw data: Figure S15-S19, Table S5 Supporting Information). The OmpF pore 
with a 600 Da molecular weight cut-off allowed Amplex (300 Da) to pass through in its “open 
state” despite being modified with a 1322.4 Da Gala3 peptide, which indicates that Gala3 is 
extended outside of the pore at pH 7.4. Various molecular factors might be responsible for the 
bio-valve functionality of Gala3 inside the OmpF pore: change in the peptide protonation 
state, change in the peptide conformation, and different electrostatic interactions within the 
pore. Based on average pKa-values, it can be estimated that at pH 6.0 only around 2% of the 
glutamic acid groups would become protonated. Therefore, this change in the protonation 
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state of the Gala3-peptide is not the key parameter affecting the transport through the OmpF 
pore, being insufficient to explain the significant change in the in situ HRP activity (Figure 
S22, Table S8 Supporting Information). However, significant structural changes have been 
reported for the GALA-peptide: GALA is in a random coil at pH 7.4 and forms anα-helix at 
pH 5.5.48 We believe that even the short Gala3-peptide undergoes similar conformational 
changes in combination with interactions between GALA3 in the double mutant.  
Catalytic compartments containing HRP and equipped with OmpF-M were still active after 
two weeks, which is a remarkable improvement in the stability of encapsulated HRP 
compared with the free enzyme (Figure S20, Supporting Information) The reversibility of the 
stimuli response of NRC was evaluated by cycling the pH change, and measuring the HRP 
activity triggered by these cycles. (Figure 4C). With each pH cycle, new Amplex UltraRed® 
and H2O2 were added. Each time, upon a pH increase to 7.4, the NRC activity increased due 
to the opening of the OmpF-C pore, and inversely the activity decreased when the pH was 
decreased to 6.0, because the OmpF pore was closed. The activity of NRC at pH 7.4 on the 
fourth cycle slightly decreased to 75%, which can be explained by saturation effects resulting 
from successive additions of the substrate and salts61, 62. In comparison free HRP significantly 
decreased its activity in bulk after the first cycle (Fig S13). Therefore, our NRC is not only a 
reversible pH catalytic compartment, but also an ideal candidate to protect the enzymes and 
preserve their activity. Moreover, when compared to the time resolution of the enzyme 
kinetic, the change between open/closed states can be considered instantaneous. 
We successfully developed catalytic compartments with reversible triggered activity by 
inserting bio-valves in the membrane of synthetic compartments loaded with enzymes. The 
role of the bio-valves is to control the in situ activity inside catalytic nanocompartments by 
changing in a reversible manner from an “open” to a “close” state that controls the molecular 
flow through the compartment membrane. The bio-valve resulted from attachment of stimuli-
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responsive peptides to a genetically modified channel porin, OmpF. Changes in the 
conformation inside the pores, upon a pH change of 1.4 units in the environment of the 
nanocompartments block/unblock the pores of OmpF in a reversible manner. The pH-
reversible bio-valve functionality induced an in situ activity switch on/off by the molecular 
flow of substrates/products through the polymersome membrane. Compared to all stimuli-
responsive compartments reported, which either change their integrity or do not allow a 
controlled permeability, our synthetic compartments equipped with a genetically engineered 
bio-valve represent a step beyond what has been achieved to date in complex functionality. In 
addition, the encapsulation of the enzyme served both to increase the activity due to the 
confined reaction space inside the polymersomes, and to increase its stability compared to the 
free enzyme. We anticipate that further improvements to the system can be made by: i) 
expanding it for other types of stimuli associated with attachment of corresponding molecular 
groups, and ii) adjustment of the number and length of the stimuli responsive molecules to 
modulate the molecular flow through the pores. 
Our strategy to build catalytic compartments with reversible triggered functionality has the 
potential to completely change the manner in which stimuli-responsive compartments are 
developed in the future, especially but not limited to medical or catalysis applications. In 
addition, the insertion of reversible bio-valves in synthetic membranes is not limited to 
nanocompartments and can be easily expanded to planar membranes, resulting in a wide 
range of applications ranging from analytical chemistry, nanofiltration, and up to medicine.   
 
Methods. A detailed description of the reagents is found before each experimental section in 
the Supporting Information. The double cysteine mutant K89C R270C of OmpF-WT (OmpF-
M) was created to introduce thiol groups as anchor points for the attachment of stimuli 
responsive peptides. K89 C represents one lysine in 89th position, which is replaced by a 
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cysteine, whilst R270C represents one ariginine replaced by a cysteine. The plasmid bearing 
the OmpF-gene used in this work has been previously described.63 Mutations were introduced 
via site-directed mutation directly on the plasmid, by using a two-step PCR protocol64 adapted 
for the PfuTurbo DNA Polymerase (Agilent) and the corresponding primers (Table S1, 
Supporting Information). The amplicon was then purified on a 1% agarose gel using a gel-
extraction kit from QIAGEN. The amplicon was first transfected to XL1-Blue ultra-
competent cells, then extracted and sequenced prior to transfection into BL21 (DE3)Omp8.63 
This intermediate step over the ultracompetent cells was necessary to improve uptake because 
the amplicon was significantly larger than the supercoiled plasmid. 
Both OmpF-WT and the OmpF mutants (single mutants K89C-OmpF, R270C-OmpF, and the 
double mutant K89C-R270C-OmpF) were expressed following a published procedure55, with 
minor changes (see Supporting Information). The extraction of OmpF was made in PBS 
buffer containing octylglucopyranoside (3 w/w % OG; Affymetrix). The purity of OmpF was 
evaluated on a 12% SDS-PAGE gel, and the concentration of OmpF was measured 
spectrometrically at λ = 280 nm with Nanodrop (Witec Ag), and with a BCA-protein assay 
(Thermo Fischer Scientific) 
A DMSO solution of 20eq. Gala3 peptide-maleic imide per cysteine-group was slowly added 
to 1mL OmpF-M (1g/L) in PBS with 3 w/w % OG at pH=7.4, and stirred overnight at room 
temperature. OmpF-C was dialysed twice against 1L PBS containing 0.5 w/w % OG using 
Midi GeBAflex-tube (50-800µL; 6-8kDa MWCO). The solution was concentrated 2x using 
10kDa Amicon Centrifugal Filters (Milipore). 
The protein concentration was measured spectrometrically at λ = 280 nm with Nanodrop 
(Witec Ag), and the labelling efficiency was evaluated by using the acrylodane assay (details 
in Supporting Information), and mass spectrometry (applying SDS-gel for purification; in-gel 
digestion and HPLC-ESI MS on the extract).65 
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Polymersomes either without and in the presence of biomolecules (OmpF and HRP) were 
prepared by the film rehydration method of PMOXA6-b-PDMS44-b-PMOXA6 triblock 
copolymer (details in Supporting Information).66 After confirming the purity and homogeneity 
of the polymersomes using a Malvern Zetasizer (PDI < 0.1), the polymersome concentration 
of different samples has been adjusted to avoid differences by comparing their ability to 
scatter light with a Spectramax M5 spectrophotometer in semi-micro PS cuvettes (VWR). 
Light scattering experiments were performed using an ALV goniometer (ALV GmbH, 
Germany) equipped with an ALV He –Ne laser (JDS Uniphase, wavelength λ = 632.8 nm). 
The solutions after film rehydration method (polymer concentration diluted to 1.25, 0.625, 
0.313 and 0.156 g/L) were measured in a 10mm cylindrical quartz cell at angles ranging from 
30° to 150° at 293 K with angular steps of 10°. ALV/Static & Dynamic FIT and PLOT 
program version 4.31 10/10 were used for data analysis. Static light scattering data were 
processed according to the Guinier-model. 
Polymersome solutions were diluted to a polymer concentration of 0.05 g/L and 5 µL were 
negatively stained with 2% uranyl acetate solution and deposited on a carbon-coated copper 
grid. The samples were examined with a transmission electron microscope (Philips CM-100) 
operated at 80 kV. 
The activity of HRP (free and encapsulated into polymersomes equipped with or without 
OmpF-C or OmpF-M,) was measured using Amplex UltraRed® (Invitrogen) as substrate 
(500uM final concentration) and hydrogen peroxide as co-substrate (13.3uM final 
concentration). The HRP reaction was evaluated at pH 7.4 and 6.0. HRP activity was 
measured in: i) free conditions, ii) polymersomes equipped with peptide bearing OmpF-M, 
(NRC), iii) polymersome containing HRP without inserted OmpF, (NR-), and iv) 
polymersomes containing HRP and with OmpF-C inserted in the membrane, (NR+). 
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For each resulting kinetic curve based on the increase of the fluorescence intensity of the 
resorufin-derivative over time, the initial slope of the graph (0 to 200s) was taken as the initial 
activity and all values were normalised, such that the value corresponding to NR+ was set to 
100%. For the reversibility experiments, pH was adjusted with minimal amounts of 
concentrated hydrochloric acid or sodium hydroxide. HRP reaction was detected at pH 7.4, 
then the pH was decreased to 6.0 and another equivalent of Amplex UltraRed® and hydrogen 
peroxide were added and the fluorescence intensity of the resorufin-derivative was measured 
again. Then the pH was increased back to 7.4 to continue with the next cycle. 
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